South Australia Health, Endocrine Unit, Adelaide, Australia.
School of Medicine, The University of Notre Dame, Sydney, Australia.
Endocr Pract. 2021 Aug;27(8):813-818. doi: 10.1016/j.eprac.2021.04.005. Epub 2021 Apr 21.
Frequent, finger-prick capillary blood glucose measurement is standard care, used to drive insulin infusion rates for inpatients being resuscitated from diabetic ketoacidosis (DKA). Over recent years there has been a shift toward continuous interstitial glucose monitoring, allowing monitoring of glucose without repeated invasive testing. While continuous interstitial glucose monitoring has been safely and reliably utilized in the outpatient setting, it has yet to be studied in acutely unwell patients with DKA. The aim of this study, allowing for physiologically lower interstitial compared to capillary glucose, was to determine if interstitial flash glucose monitoring (FGM) would lead to insulin infusion rates that were similar to capillary blood glucose (CapBG) in DKA.
In this study, 10 patients with diabetes mellitus, assessed to be in DKA, were enrolled. At the same time as standard DKA management commencement, simultaneous FGM measurements were obtained. Duplicate paired glucose readings were then analyzed for agreement.
Actual (CapBG-driven) and predicted (FGM determined) insulin infusion rates were similar. Minor differences in predicted insulin infusion rates were noted in 2/10 patients at higher glucose concentrations, which may relate to the lag in change in glucose in the interstitial space.
Based on our results, a trial of clinical outcomes in patients with DKA treated with insulin infusion rates driven by CapBG versus subcutaneous FGM appears justified. The FGM method of testing may improve patient comfort, obviate fatigue, improve staff time and direct patient contact, and potentially facilitate rapid discharge.
频繁的指尖毛细血管血糖测量是标准护理,用于驱动糖尿病酮症酸中毒(DKA)患者的胰岛素输注率。近年来,连续间质葡萄糖监测已逐渐取代,无需重复的有创检测即可监测血糖。虽然连续间质葡萄糖监测已在门诊环境中安全可靠地使用,但尚未在患有 DKA 的急性不适患者中进行研究。本研究旨在允许间质葡萄糖与毛细血管葡萄糖相比具有生理上更低的数值,以确定间质瞬态葡萄糖监测(FGM)是否会导致与毛细血管血糖(CapBG)相似的胰岛素输注率。
本研究纳入了 10 名患有糖尿病且被评估为 DKA 的患者。在开始标准 DKA 管理的同时,同时获得 FGM 测量值。然后分析重复配对的血糖读数以确定一致性。
实际(CapBG 驱动)和预测(FGM 确定)胰岛素输注率相似。在 2/10 名患者中,在较高的葡萄糖浓度下,预测胰岛素输注率存在较小差异,这可能与间质葡萄糖变化的滞后有关。
根据我们的结果,对于接受 CapBG 驱动的胰岛素输注率治疗的 DKA 患者,进行临床结局试验似乎是合理的,与皮下 FGM 相比。测试的 FGM 方法可能会提高患者舒适度,避免疲劳,提高员工时间和与患者的直接接触,并可能促进快速出院。